Search
for
Sort by
Research 28
- Biologics in the management of childhood atopic dermatitis
- Novel drugs of United States Food and Drug Administration approved in 2024
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Postępowanie kosmetologiczne w wybranych jednostkach chorobowych : podręcznik dla studentów kosmetologii oraz kierunków medycznych
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- BI35 A case of dupilumab-induced scalp psoriasis and review of the literature
- Novel investigational drugs for alopecia areata and future perspectives
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Topical corticosteroid in foam vehicle offers comparable coverage compared with traditional vehicles
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Type 2 Cytokine–Dependent Skin Barrier Regulation in Personalized 2-Dimensional and 3-Dimensional Skin Models of Atopic Dermatitis: A Pilot Study
- Effects of natural products on skin inflammation caused by abnormal hormones secreted by the adrenal gland
- A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
- The first 20 years of skin of color dermatology: An era of advancements in skin, hair, and nail disorders
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Hypothesis: platelet-rich plasma as an adjunct therapy for eczema targeting inflammation, skin barrier repair, and chronic recurrence
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- A Pilot Investigation of a Gummy-Based Hair Nutraceutical: Preliminary Efficacy Findings
- Race and Ethnicity Sub-Groups of Alopecia Areata Patients have Differing Clinical Characteristics: TARGET-DERM AA
- Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia